The overall goal of this work is to reduce death and disability from intracerebral hemorrhage, which accounts for 10-30% of all strokes worldwide and is the deadliest and most disabling type of stroke. With no approved hyperacute medical treatments for intracerebral hemorrhage, development of safe and effective therapy is urgently needed.